|

Verteporfin Clinical Trials

3 actively recruiting trials across 3 locations

▼ -1 trial since June 2026

Also known as: BPD-MA, Benzoporphyrin Derivative Monoacid Ring A, Visudyne

Pipeline

Phase 1/2: 3

Top Sponsors

  • SpectraCure AB1
  • Roswell Park Cancer Institute1
  • Emory University1

Indications

  • Cancer3
  • Recurrent Prostate Cancer1
  • Recurrent Glioblastoma1
  • Malignant Solid Neoplasm1
  • Glioblastoma1

Atlanta, Georgia1 trial

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

Emory University Hospital/Winship Cancer Institute

Phase 1/2

Buffalo, New York1 trial

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

Roswell Park Cancer Institute

Phase 1/2

New York, New York1 trial

Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

Memorial Sloan Kettering Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.